Bioelectronics Corp (BIEL)

[rodman]

Biel is doing well after the reorganization and the chairman Staelin and team are implementing the program.
11/26/20
"Two other firms have also placed orders to sell our device in the domestic OTC market. However, they have yet to distribute their products into retail and thus we are not able to identify them. With this noted, both will be receiving delivery of units in December and thus we anticipate booking sales to these customers in fourth quarter 2020. (These two customers anticipate selling into their retail markets in first quarter 2021.)

Modifying the product design and building up production capability

One of our customers wanted major design changes to our 720 hour device. This required extensive internal design changes to the device and modifications of the manufacturing processes. In addition this customer wanted to completely redesign the packaging. (KT Tape) Coordinating all these changes resulted in extensive communications with the customer’s design team (and their top management) KT CEO as well as nightly calls to our overseas manufacturer.
.05